Evidence map›Paper›PMID 37991018›Full record

ArticleJCI insight2023

Smooth muscle-derived adventitial progenitor cells direct atherosclerotic plaque composition complexity in a Klf4-dependent manner.

Allison M Dubner, Sizhao Lu, Austin J Jolly, Keith A Strand, Marie F Mutryn, Tyler Hinthorn, Tysen Noble, Raphael A Nemenoff, Karen S Moulton, Mark W Majesky and 1 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Allison M DubnerDepartment of Medicine, Division of Renal Diseases and Hypertension.
Sizhao LuDepartment of Medicine, Division of Renal Diseases and Hypertension.
Austin J JollyDepartment of Medicine, Division of Renal Diseases and Hypertension.
Keith A StrandDepartment of Medicine, Division of Renal Diseases and Hypertension.
Marie F MutrynDepartment of Medicine, Division of Renal Diseases and Hypertension.
Tyler HinthornDepartment of Medicine, Division of Renal Diseases and Hypertension.
Tysen NobleDepartment of Medicine, Division of Renal Diseases and Hypertension.
Raphael A NemenoffDepartment of Medicine, Division of Renal Diseases and Hypertension.
Karen S MoultonDepartment of Medicine, Division of Cardiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Mark W MajeskyCenter for Developmental Biology & Regenerative Medicine, Seattle Children's Research Institute, Seattle, Washington, USA.
Mary Cm Weiser-EvansDepartment of Medicine, Division of Renal Diseases and Hypertension.
Hypertension Institute · USCystic Fibrosis Trust · GBIntegrated Oncology (United States) · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Washington · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Reprogramming of mature smooth muscle cells to vascular progenitor cellsR01HL121877 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MARK W. MAJESKY, Mary CM Weiser-Evans · 2015 to 2026
$7.8M
NRSA Training CoreTL1TR002533 · NCATS · UNIVERSITY OF COLORADO DENVER · PI CICUTTO, LISA · 2018 to 2022
$3.0M
Understanding the Molecular Mechanisms of Fibromuscular DysplasiaR01HL148167 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KADIAN-DODOV, DANIELLA, KOVACIC, JASON CIRIL · 2020 to 2023
$2.8M
PTEN promoter hypermethylation underlies vascular disease progressionR01HL151331 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI WEISER-EVANS, MARY CM · 2021 to 2024
$2.3M
Role of Smooth Muscle-derived Vascular Progenitor Cells (AdvSca1-SM) in Vasa Vasorum Expansion and Atherosclerotic Plaque ProgressionF31HL160149 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DUBNER, ALLISON M · 2021 to 2023
$86k
NCATS NIH HHS TL1 TR002533NCI NIH HHS P30 CA046934NHLBI NIH HHS F31 HL160149NHLBI NIH HHS R01 HL121877NHLBI NIH HHS R01 HL148167NHLBI NIH HHS R01 HL151331
6 · The paper itself

Abstract

We previously established that vascular smooth muscle-derived adventitial progenitor cells (AdvSca1-SM) preferentially differentiate into myofibroblasts and contribute to fibrosis in response to acute vascular injury. However, the role of these progenitor cells in chronic atherosclerosis has not been defined. Using an AdvSca1-SM cell lineage tracing model, scRNA-Seq, flow cytometry, and histological approaches, we confirmed that AdvSca1-SM-derived cells localized throughout the vessel wall and atherosclerotic plaques, where they primarily differentiated into fibroblasts, smooth muscle cells (SMC), or remained in a stem-like state. Krüppel-like factor 4 (Klf4) knockout specifically in AdvSca1-SM cells induced transition to a more collagen-enriched fibroblast phenotype compared with WT mice. Additionally, Klf4 deletion drastically modified the phenotypes of non-AdvSca1-SM-derived cells, resulting in more contractile SMC and atheroprotective macrophages. Functionally, overall plaque burden was not altered with Klf4 deletion, but multiple indices of plaque composition complexity, including necrotic core area, macrophage accumulation, and fibrous cap thickness, were reduced. Collectively, these data support that modulation of AdvSca1-SM cells through KLF4 depletion confers increased protection from the development of potentially unstable atherosclerotic plaques.

Indexed as

Plaque, AtheroscleroticAnimalsKruppel-Like Factor 4MiceMuscle, SmoothMyocytes, Smooth MuscleStem CellsKruppel-Like Factor 4Adult stem cellsAtherosclerosisStem cellsVascular Biology

Identifiers

PMID37991018
PMCPMC10755692
OpenAlexW4388857144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.